Research has shown how stress changes the structure of the brain and reveals a potential therapeutic target to the prevent or reverse it. Led by Si-Qiong June Liu, MD, PhD, Professor of Cell Biology and Anatomy at LSU Health New Orleans School of Medicine, the findings are published in JNeurosci.
Why Parkinson’s disease and other neurological disorders impact one side of the body before the other is explained in recent findings.
White Matter – the brain’s wiring system is part of intelligence, not just grey matter.
According to new study, the risk appears to be more prominent in women than in men.
Taking a low-dose aspirin once a day does not reduce the risk of thinking and memory problems caused by mild cognitive impairment or probable Alzheimer’s disease, nor does it slow the rate of cognitive decline, according to a large study published in the online issue of Neurology®, the medical journal of the American Academy of Neurology.
Osaka University-led research finds predictions of better response to extracorporeal cardiopulmonary resuscitation (ECPR), which can improve blood flow.
UNIGE researchers have shown that the decline in cognitive abilities after 50 years of age results in a decline in physical activity, and that – contrary to what has been suggested by the literature to date – the inverse relationship is much weaker.
Study finds that the brain focuses on benefits instead of costs of work with Ritalin and similar medications
New research from cognitive neuroscientists at Brown and Radboud Universities has pinpointed how stimulants such as Ritalin and Adderall can change people’s motivation to complete difficult tasks.
After a stroke, there is an increased risk of suffering a second one. If areas in the left hemisphere were affected during the first attack, language is often impaired. In order to maintain this capability, the brain usually briefly drives up the counterparts on the right side. But what happens after a second attack? Medical researchers have now found an answer by using virtual lesions.
A Melbourne led study has uncovered a new neurodegenerative disorder in which children experience developmental regression and severe epilepsy.